Table 3.
Baseline characteristics | |
Demographic data | |
Male sex, n (%) | 1006 (73.4%) |
Age (years) median (IQRs) | 49.0 (40.0–59.0) |
HBV-related, n (%) | 952 (69.5%) |
Cirrhosis, n (%) | 973 (71.1%) |
Laboratory data, median (IQRs) | |
Total bilirubin (mg/dL) | 3.9 (1.5–13.7) |
INR | 1.41 (1.17–1.79) |
Serum creatinine (mg/dL) | 0.78 (0.65–0.96) |
ALT (U/L) | 82 (29–383) |
AST (U/L) | 101 (46–265) |
γ-GT (U/L) | 82 (38–158) |
AKP (U/L) | 125 (92–63) |
Albumin (g/L) | 32.3 (28.1–37.0) |
CRP (mg/L) | 7.3 (3.1–14.6) |
WBC (×109/L) | 4.95 (3.69–7.06) |
Hb (g/L) | 118 (94–136) |
Platelet count (×109/L) | 96.0 (61.0–150.0) |
Serum sodium (mmol/L) | 138 (136–141) |
Patients with AD | 1083 (79.1%) |
Type of AD | |
Overt ascites | 558 (40.7%) |
Gastrointestinal bleeding | 224 (16.4%) |
HE | 105 (7.7%) |
Jaundice | 611 (44.6%) |
Infection | 218 (15.9%) |
Score | |
MELD score | 15 (10–22) |
Child-Pugh score | 8 (7–10) |
Child-Pugh grade | |
Child-Pugh A, n (%) | 261 (19.1%) |
Child-Pugh B, n (%) | 533 (38.9%) |
Child-Pugh C, n (%) | 576 (42.0%) |
AD, acute decompensation; AKP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C reactive protein; γ-GT, γ-glutamyl transferase; Hb, haemoglobin; HBV, hepatitis B virus; HE, hepatic encephalopathy; INR, international standardisation ratio; MELD, the Model for End-stage Liver Disease; WBC, white cell count.